Skip to main content
Signal8
Seven Fleet Capital Management LP logo

Seven Fleet Capital Management LP

CIK: 2092021

Last 13F

Nov 16, 2026

Next 13F

Feb 15, 2027 · in 3mo

13F Portfolio Value

$511.73M

Not total AUM

Holdings (85)

Q3 2026 13F, quarter ended Sep 30, 2026, filed Nov 16, 2026

  • CG ONCOLOGY INC logo
    CGON

    CG ONCOLOGY INC

    $133.72M

    1.89M sh26.13%+0.0%
  • TANGO THERAPEUTICS INC logo
    TNGX

    TANGO THERAPEUTICS INC

    $55.71M

    2.23M sh10.89%-30.8%
  • REVOLUTION MEDICINES INC logo
    RVMD

    REVOLUTION MEDICINES INC

    $54.31M

    264,588 sh10.61%+9.3%
  • PHARVARIS N V logo
    PHVS

    PHARVARIS N V

    $22.21M

    700,084 sh4.34%-9.6%
  • ENTERA BIO LTD logo
    ENTX

    ENTERA BIO LTD

    $19.97M

    6.86M sh3.90%+3486.4%
  • LIQUIDIA CORPORATION logo
    LQDA

    LIQUIDIA CORPORATION

    $18.04M

    596,275 sh3.53%+132.4%
  • ARRIVENT BIOPHARMA INC logo
    AVBP

    ARRIVENT BIOPHARMA INC

    $13.66M

    451,173 sh2.67%+83.0%
  • ENLIVEN THERAPEUTICS INC logo
    ELVN

    ENLIVEN THERAPEUTICS INC

    $12.01M

    261,957 sh2.35%-28.3%
  • AVALO THERAPEUTICS INC logo
    AVTX

    AVALO THERAPEUTICS INC

    $11.84M

    772,660 sh2.31%+0.3%
  • XENCOR INC logo
    XNCR

    XENCOR INC

    $11.1M

    444,937 sh2.17%+20.8%
  • ROIVANT SCIENCES LTD logo
    ROIV

    ROIVANT SCIENCES LTD

    $10.62M

    290,280 sh2.07%+31.9%
  • ABIVAX SA logo
    ABVX

    ABIVAX SA

    $9.83M

    99,274 sh1.92%-10.8%
  • ASSEMBLY BIOSCIENCES INC logo
    ASMB

    ASSEMBLY BIOSCIENCES INC

    $9.81M

    417,441 sh1.92%-3.6%
  • VERADERMICS INC logo
    MANE

    VERADERMICS INC

    $9.7M

    80,000 sh1.90%+0.0%
  • PROTAGONIST THERAPEUTICS INC logo
    PTGX

    PROTAGONIST THERAPEUTICS INC

    $6.43M

    45,659 sh1.26%+0.6%
  • DAMORA THERAPEUTICS INC logo
    DMRA

    DAMORA THERAPEUTICS INC

    $6.14M

    288,439 sh1.20%New
  • CENTURY THERAPEUTICS INC logo
    IPSC

    CENTURY THERAPEUTICS INC

    $6.08M

    4.42M sh1.19%+1.7%
  • EUPRAXIA PHARMACEUTICALS INC logo
    EPRX

    EUPRAXIA PHARMACEUTICALS INC

    $5.21M

    572,267 sh1.02%-6.3%
  • AXSOME THERAPEUTICS INC. logo
    AXSM

    AXSOME THERAPEUTICS INC.

    $4.44M

    24,066 sh0.87%-16.5%
  • SAGIMET BIOSCIENCES INC logo
    SGMT

    SAGIMET BIOSCIENCES INC

    $4.24M

    429,113 sh0.83%+6.3%
  • ZENTALIS PHARMACEUTICALS INC logo
    ZNTL

    ZENTALIS PHARMACEUTICALS INC

    $4.17M

    1.50M sh0.81%+373.6%
  • DEFINIUM THERAPEUTICS INC logo
    DFTX

    DEFINIUM THERAPEUTICS INC

    $4.14M

    108,647 sh0.81%-26.9%
  • DIANTHUS THERAPEUTICS INC logo
    DNTH

    DIANTHUS THERAPEUTICS INC

    $4.09M

    46,432 sh0.80%-28.3%
  • SILENCE THERAPEUTICS PLC logo
    SLN

    SILENCE THERAPEUTICS PLC

    $3.83M

    350,000 sh0.75%+482.3%
  • TARSUS PHARMACEUTICALS INC logo
    TARS

    TARSUS PHARMACEUTICALS INC

    $3.81M

    48,530 sh0.75%-58.5%
  • IMMUNIC INC logo
    IMUX

    IMMUNIC INC

    $3.66M

    687,240 sh0.72%New
  • TAYSHA GENE THERAPIES INC logo
    TSHA

    TAYSHA GENE THERAPIES INC

    $3.65M

    750,000 sh0.71%-50.1%
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    $3.54M

    53,748 sh0.69%-54.5%
  • MINERVA NEUROSCIENCES INC logo
    NERV

    MINERVA NEUROSCIENCES INC

    $3.35M

    1.00M sh0.66%+0.0%
  • RELAY THERAPEUTICS INC logo
    RLAY

    RELAY THERAPEUTICS INC

    $3.35M

    185,733 sh0.66%+4.2%
  • ZAI LAB LTD logo
    ZLAB

    ZAI LAB LTD

    $3.12M

    118,395 sh0.61%-13.0%
  • PRAXIS PRECISION MEDICINES I logo
    PRAX

    PRAXIS PRECISION MEDICINES I

    $3.05M

    10,489 sh0.60%+39.1%
  • CYTOMX THERAPEUTICS INC. logo
    CTMX

    CYTOMX THERAPEUTICS INC.

    $2.95M

    1.09M sh0.58%+0.0%
  • EDITAS MEDICINE INC logo
    EDIT

    EDITAS MEDICINE INC

    $2.94M

    1.92M sh0.58%+44.0%
  • SAB BIOTHERAPEUTICS INC logo
    SABS

    SAB BIOTHERAPEUTICS INC

    $2.39M

    752,772 sh0.47%+2.3%
  • ASCENDIS PHARMA A/S logo
    ASND

    ASCENDIS PHARMA A/S

    $2.15M

    9,440 sh0.42%-20.5%
  • ADLAI NORTYE GROUP LTD logo
    ANL

    ADLAI NORTYE GROUP LTD

    $1.86M

    116,185 sh0.36%+2.6%
  • SUTRO BIOPHARMA INC logo
    STRO

    SUTRO BIOPHARMA INC

    $1.61M

    99,894 sh0.31%-37.2%
  • UNITED THERAPEUTICS CORP DEL logo
    UTHR

    UNITED THERAPEUTICS CORP DEL

    $1.59M

    2,940 sh0.31%New
  • INVENTIVA SA logo
    IVA

    INVENTIVA SA

    $1.53M

    414,341 sh0.30%+107.0%
  • HARMONY BIOSCIENCES HLDGS IN logo
    HRMY

    HARMONY BIOSCIENCES HLDGS IN

    $1.49M

    37,900 sh0.29%New
  • AN2 THERAPEUTICS INC logo
    ANTX

    AN2 THERAPEUTICS INC

    $1.35M

    254,309 sh0.26%+21.7%
  • CELLDEX THERAPEUTICS INC NEW logo
    CLDX

    CELLDEX THERAPEUTICS INC NEW

    $1.32M

    40,868 sh0.26%-52.8%
  • SUMMIT THERAPEUTICS INC logo
    SMMT

    SUMMIT THERAPEUTICS INC

    $1.3M

    76,648 sh0.25%+4.6%
  • VAXCYTE INC logo
    PCVX

    VAXCYTE INC

    $1.26M

    22,066 sh0.25%-25.9%
  • TCGX ACQUISITION CORP logo
    TCGX

    TCGX ACQUISITION CORP

    $1.25M

    100,000 sh0.24%New
  • CONTINEUM THERAPEUTICS INC logo
    CTNM

    CONTINEUM THERAPEUTICS INC

    $1.16M

    86,654 sh0.23%+43.1%
  • BIOHAVEN LTD logo
    BHVN

    BIOHAVEN LTD

    $1.08M

    81,221 sh0.21%New
  • SPYRE THERAPEUTICS INC logo
    SYRE

    SPYRE THERAPEUTICS INC

    $1.03M

    11,611 sh0.20%-12.7%
  • INMED PHARMACEUTICALS INC logo
    INM

    INMED PHARMACEUTICALS INC

    $1M

    1.07M sh0.20%New

1-50 of 85

Sector Allocation

SEC Filings

FormDescriptionFiled

Seven Fleet Capital Management LP filed its most recent 13F holdings report, covering Q3 2026 (the quarter ended Sep 30, 2026), on Nov 16, 2026. Its largest reported positions by value are CGON, TNGX, RVMD, PHVS and ENTX. A 13F lists US-listed stock and option positions, not total assets under management.

About Seven Fleet Capital Management LP

Seven Fleet Capital Management LP is an Investment Adviser that reports its US-listed stock and option positions to the SEC on Form 13F (CIK 2092021). Signal8 holds 12 13F filings from it. Its SEC filings list California as its state of incorporation.

Its most recent 13F holdings report covers Q3 2026 (the quarter ended Sep 30, 2026) and was filed on Nov 16, 2026. That report lists 85 securities, not counting options, down from 96 in Q2 2026.

Its five largest reported positions, in order, are CG ONCOLOGY INC (CGON), TANGO THERAPEUTICS INC (TNGX), REVOLUTION MEDICINES INC (RVMD), PHARVARIS N V (PHVS) and ENTERA BIO LTD (ENTX). The next five are LIQUIDIA CORPORATION (LQDA), ARRIVENT BIOPHARMA INC (AVBP), ENLIVEN THERAPEUTICS INC (ELVN), AVALO THERAPEUTICS INC (AVTX) and XENCOR INC (XNCR).

Recent 13F filings by Seven Fleet Capital Management LP

  • Q3 2026: 13F-HR filed Nov 16, 2026, listing 85 securities.
  • Q2 2026: 13F-HR filed Aug 14, 2026, listing 96 securities.
  • Q1 2026: 13F-HR/A filed Jun 4, 2026, listing 115 securities.
  • Q1 2026: 13F-HR filed May 15, 2026, listing 114 securities.
  • Q4 2025: 13F-HR/A filed Apr 1, 2026, listing 85 securities.
  • Q4 2025: 13F-HR filed Feb 26, 2026, listing 85 securities.

What a Form 13F does and does not show